These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 815811)

  • 1. In vivo cytogenetic activity of sulphonylurea drugs in man.
    Watson WA; Petrie JC; Galloway DB; Bullock I; Gilbert JC
    Mutat Res; 1976 Feb; 38(1):71-80. PubMed ID: 815811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of relapse in elderly diabetic patients admitted with sulphonylurea-induced severe hypoglycaemic attacks.
    Chan TY; Cheung AY
    Age Ageing; 1997 Sep; 26(5):409-10. PubMed ID: 9351488
    [No Abstract]   [Full Text] [Related]  

  • 3. Oral treatment in diabetes.
    Stowers JM
    Clin Endocrinol Metab; 1972 Nov; 1(3):721-50. PubMed ID: 4204135
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hypoglycemic accidents during treatment with antidiabetic sulfamides. Apropos of 5 cases of hypoglycemic coma in aged subjects].
    Brogard JM; Kuntzmann F; Touitou D; Dorner M
    Sem Hop; 1973 Sep; 49(37):2461-6. PubMed ID: 4359498
    [No Abstract]   [Full Text] [Related]  

  • 5. Sulphonylurea and hypothyroidism in Nigerian diabetic subjects.
    Adadevoh BK
    J Int Med Res; 1976; 4(5):364-6. PubMed ID: 1028637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glyburide and glipizide, second-generation oral sulfonylurea hypoglycemic agents.
    Prendergast BD
    Clin Pharm; 1984; 3(5):473-85. PubMed ID: 6435940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromosomal studies in diabetic patients treated with chlorpropamide.
    Kulkarni PS; Ambani LM; Bhandarkar SD
    Food Chem Toxicol; 1985 Jun; 23(6):625-8. PubMed ID: 4040109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SUR receptor activity vs. incidence of hypoglycaemia and cardiovascular mortality with sulphonylurea therapy for diabetics.
    Tayek J
    Diabetes Obes Metab; 2008 Nov; 10(11):1128-9; author reply 1129-30. PubMed ID: 18671799
    [No Abstract]   [Full Text] [Related]  

  • 9. Editorial: Oral therapy in diabetes mellitus.
    Scoville AB
    South Med J; 1974 Jun; 67(6):635-8. PubMed ID: 4208385
    [No Abstract]   [Full Text] [Related]  

  • 10. Lichenoid drug reactions to chlorpropamide and tolazamide.
    Barnett JH; Barnett SM
    Cutis; 1984 Dec; 34(6):542-4. PubMed ID: 6240374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Case of hypersensitivity to sulfonylurea compounds].
    Batko B
    Wiad Lek; 1983 May; 36(9):761-3. PubMed ID: 6613126
    [No Abstract]   [Full Text] [Related]  

  • 12. The pharmacology of sulfonylureas.
    Skillman TG; Feldman JM
    Am J Med; 1981 Feb; 70(2):361-72. PubMed ID: 6781341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of the severity of nephropathy in aging Fischer 344 rats treated with analogs of arylsulfonyluria.
    Milman HA; Peckham JC; Ward JM; Tarone RE
    Toxicol Appl Pharmacol; 1979 Jul; 49(3):425-30. PubMed ID: 473209
    [No Abstract]   [Full Text] [Related]  

  • 14. Profound hypoglycemia with the addition of a tricyclic antidepressant to maintenance sulfonylurea therapy.
    True BL; Perry PJ; Burns EA
    Am J Psychiatry; 1987 Sep; 144(9):1220-1. PubMed ID: 3631324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolazamide-induced cholestasis.
    Bridges ME; Pittman FE
    South Med J; 1980 Aug; 73(8):1072-4. PubMed ID: 7403921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical use of the sulfonylurea drugs.
    Blumenthal SA; Moses AM
    Compr Ther; 1976 Jul; 2(2):53-8. PubMed ID: 954381
    [No Abstract]   [Full Text] [Related]  

  • 17. [88 severe incidents of hypoglycemia in patients under treatment with sulfonylurea compounds. Results of a survey throughout Switzerland during 1968 and 1969].
    Berger W
    Schweiz Med Wochenschr; 1971 Jul; 101(28):1013-22. PubMed ID: 5141777
    [No Abstract]   [Full Text] [Related]  

  • 18. [Glibenclamide and diabetes mellitus. 1. Year's clinical experience].
    Contreras AR; Gabrielli S; Baigorria L
    Prensa Med Argent; 1972 May; 59(15):581-3. PubMed ID: 4626172
    [No Abstract]   [Full Text] [Related]  

  • 19. Intramuscular or intravenous glucagon for sulphonylurea hypoglycaemia?
    Taylor JR; Sherratt HS; Davies DM
    Eur J Clin Pharmacol; 1978 Nov; 14(2):125-7. PubMed ID: 363433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glibenclamide, a new sulphonylurea: whither oral hypoglycaemic agents?
    Marble A
    Drugs; 1971; 1(2):109-15. PubMed ID: 4999930
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.